Nu Skin Enterprises (NYSE:NUS) Updates Q1 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its first quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.100-0.200 for the period, compared to the consensus estimate of 0.290. The company issued revenue guidance of $320.0 million-$340.0 million, compared to the consensus revenue estimate of $382.7 million. Nu Skin Enterprises also updated its FY 2026 guidance to 0.800-1.200 EPS.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on NUS shares. Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research note on Friday, January 30th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Nu Skin Enterprises Trading Down 19.2%

Shares of NYSE:NUS traded down $1.97 during mid-day trading on Friday, reaching $8.25. 419,591 shares of the company were exchanged, compared to its average volume of 458,583. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.15 and a quick ratio of 1.45. The firm’s 50-day simple moving average is $10.37 and its 200 day simple moving average is $10.65. Nu Skin Enterprises has a 1 year low of $5.32 and a 1 year high of $14.62. The firm has a market cap of $401.94 million, a price-to-earnings ratio of 3.80 and a beta of 1.01.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 12th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.01). The firm had revenue of $370.32 million for the quarter, compared to analyst estimates of $382.70 million. Nu Skin Enterprises had a return on equity of 9.15% and a net margin of 7.02%.Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. Equities research analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 11th. Shareholders of record on Friday, February 27th will be given a $0.06 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.9%. Nu Skin Enterprises’s dividend payout ratio is currently 11.01%.

Key Stories Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Management reiterated a strategic transformation and growth initiatives — Nu Skin is targeting placement of 100,000 Prysm iO devices in 2026 and signaled expansion in India, which could drive new recurring revenue and product differentiation if adoption scales. Article Title
• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (record Feb. 27, payable Mar. 11), supporting income-oriented holders and signaling confidence in cash generation. Article Title
• Positive Sentiment: Company reported full-year 2025 results “within guidance” and noted more than 50% growth in adjusted earnings for the year, an operational positive versus prior-year comparatives. Article Title
• Neutral Sentiment: Full Q4 earnings and investor materials (slides, call transcript) are available for deeper review — useful for modeling revenue mix, geography trends and margin drivers. Article Title
• Neutral Sentiment: Company provided Q&A and call transcripts (Seeking Alpha / Motley Fool) that detail product rollout timing and cost assumptions — read for color on cadence and execution risk. Article Title
• Negative Sentiment: Q4 results missed estimates: EPS $0.29 vs. $0.30 expected and revenue $370.3M vs. $382.7M consensus — the top-line miss and a year-over-year revenue decline pressured the report. Article Title
• Negative Sentiment: Near-term guidance was materially lower than Street expectations: Q1 2026 EPS guided to $0.10–0.20 (consensus ~$0.29) and FY 2026 EPS to $0.80–1.20 (consensus ~$1.42); revenue guidance also trails consensus — this downtick in forward numbers is the primary driver of the share weakness. Article Title
• Negative Sentiment: Customer base and affiliate counts declined (~10% fewer customers reported) and management cited FX and competitive headwinds — signals that near-term organic growth remains challenged. Article Title

Institutional Trading of Nu Skin Enterprises

Institutional investors have recently bought and sold shares of the business. Wexford Capital LP acquired a new position in Nu Skin Enterprises in the third quarter valued at approximately $40,000. Banque Cantonale Vaudoise purchased a new position in shares of Nu Skin Enterprises during the third quarter worth approximately $57,000. Tower Research Capital LLC TRC increased its holdings in shares of Nu Skin Enterprises by 107.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after acquiring an additional 2,614 shares during the period. Quadrant Capital Group LLC purchased a new stake in Nu Skin Enterprises in the 3rd quarter valued at $85,000. Finally, National Bank of Canada FI boosted its stake in Nu Skin Enterprises by 1,040,200.0% during the 3rd quarter. National Bank of Canada FI now owns 10,403 shares of the company’s stock worth $127,000 after purchasing an additional 10,402 shares during the period. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.